First Light Asset Management LLC purchased a new stake in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 6,431,799 shares of the company's stock, valued at approximately $3,366,000. First Light Asset Management LLC owned about 1.08% of Senseonics as of its most recent filing with the SEC.
A number of other hedge funds have also modified their holdings of SENS. Northern Trust Corp raised its stake in shares of Senseonics by 11.2% during the 4th quarter. Northern Trust Corp now owns 1,194,960 shares of the company's stock valued at $625,000 after buying an additional 120,441 shares during the last quarter. Beck Mack & Oliver LLC purchased a new position in Senseonics during the fourth quarter valued at approximately $79,000. XTX Topco Ltd acquired a new position in Senseonics in the fourth quarter valued at approximately $179,000. Raymond James Financial Inc. purchased a new stake in Senseonics in the 4th quarter worth approximately $26,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Senseonics during the 4th quarter worth approximately $720,000. 12.36% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
SENS has been the topic of a number of recent analyst reports. Mizuho began coverage on shares of Senseonics in a report on Thursday, April 10th. They set an "outperform" rating and a $2.00 price target on the stock. HC Wainwright restated a "buy" rating and issued a $2.00 price target on shares of Senseonics in a research note on Wednesday, March 5th.
Read Our Latest Report on SENS
Senseonics Price Performance
Shares of SENS stock traded down $0.02 on Thursday, reaching $0.72. 1,568,378 shares of the company were exchanged, compared to its average volume of 6,319,520. The company has a market cap of $473.06 million, a price-to-earnings ratio of -5.56 and a beta of 0.84. Senseonics Holdings, Inc. has a 1 year low of $0.25 and a 1 year high of $1.40. The business has a 50-day moving average price of $0.67 and a 200 day moving average price of $0.61. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.
Senseonics (NYSE:SENS - Get Free Report) last announced its earnings results on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same period last year, the firm posted ($0.07) EPS. Equities research analysts forecast that Senseonics Holdings, Inc. will post -0.14 earnings per share for the current fiscal year.
About Senseonics
(
Free Report)
Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
Further Reading

Before you consider Senseonics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Senseonics wasn't on the list.
While Senseonics currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.